PMA device
Blood Tubing System for the Liposorber LA-15 System
Kaneka Pharma America Corp. · Lipoprotein, Low Density, Removal (MMY, Class III) · First FDA decision Jun 18, 2010, newest Jun 18, 2010Coronary artery disease
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
38
Naming "Blood Tubing"
MAUDE reports
262
Brand "Blood Tubing", since 2015
PubMed studies
64
Mentioning "Blood Tubing"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Blood Tubing System for the Liposorber LA-15 System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- BLOOD TUBING SYSTEM FOR THE LIPOSORBER LA-15 SYSTEMPMA supplement
P910018-S013 · Decided Jun 18, 2010 · 234 days after receipt · Normal 180 Day Track No User Fee
Device type: Lipoprotein, low density, removal (MMY) · GI, Urology & Nephrology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Blood Tubing", any status and sponsor, newest update first.
- Diastolic Performance and Norepinephrine in Spinal-Induced Hypotension for Cesarean DeliveryCompleted
Fondazione Policlinico Universitario Agostino Gemelli IRCCSAcademic, hospital or other
NCT04560634 · 40 participants · Start Oct 10, 2019 · Primary completion Dec 15, 2020
Device: ClearSight®, Edwards Lifescience, Irvine, CA · For: Hypotension
Sites: Rome, Italy
37 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Blood Tubing", and for the whole product code for context.
This brand
262 reports: 181 malfunction, 51 injury, 30 death
Whole product code MMY
19 reports: 1 malfunction, 16 injury, 2 death
Newest reports for this brand
- 5008X HD/HDF With CLiC Blood Tubing SetMalfunction
ERIKA DE REYNOSA, S.A. DE C.V.
0008030665-2026-02934 · Received Oct 29, 2026 · Event dated Oct 21, 2026
Device type: Set, Tubing, Blood, With And Without Anti-Regurgitation Valve (FJK)
Device problem as coded: Fluid/Blood Leak
Patient problem as coded: Hemorrhage/Blood Loss/Bleeding
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0900-2022 · Started Feb 17, 2022
Reason given: Labeling change to due to the risk of severe anaphylactoid reactions including shock in patients treated with the Liposorber LA-15 LDL Adsorption Column under concomitant ACE inhibitor medication treatment.
Cause as FDA categorized it: Error in labeling · Device type: Lipoprotein, Low Density, Removal (MMY)
Published research
The most relevant PubMed records for "Blood Tubing"[tiab]. The summary above synthesizes these.
- Hemolysis in a Patient during Hemodialysis.
Taghavi M, Jacobs L, Kaysi S, et al. · Case Rep Nephrol Dial · 2021Case Reports
- Vitamin E-Coated Dialyzer Inhibits Oxidative Stress.
Yamadera S, Nakamura Y, Inagaki M, et al. · Blood Purif · 2017
- ECMOve: A Mobilization Device for Extracorporeal Membrane Oxygenation Patients.
van Galen DJM, Meinders Q, Halfwerk FR, et al. · ASAIO J · 2024
- The Allient dialysis system.
Ash SR · Semin Dial · 2004
- Microbial contamination of haemodialysis catheter connections.
Gorke A · EDTNA ERCA J · 2005Research Support, Non-U.S. Gov't
- Pathological perspective reveals a novel hemodialyzer reaction: a case report.
Lou W, Xi Y, Liu Y, et al. · BMC Nephrol · 2025Case Reports
- Clinical waste generation from renal units: implications and solutions.
Hoenich NA, Levin R, Pearce C · Semin Dial · 2005Review
- The ideal home hemodialysis machine.
Kjellstrand CM, Kjellstrand P · Hemodial Int · 2008Review
- Efficacy of Rapid Fluid Administration Using Various Setups and Devices.
Balaban O, Walia H, Tumin D, et al. · Pediatr Emerg Care · 2019Observational Study
- Annual Iron Loss Associated with Hemodialysis.
Tsukamoto T, Matsubara T, Akashi Y, et al. · Am J Nephrol · 2016
- Biomaterials for blood tubing: the application of plasticised poly(vinyl chloride).
Blass CR, Jones C, Courtney JM · Int J Artif Organs · 1992Comparative Study, Editorial
- Warming blood products for transfusion to neonates: In vitro assessments.
Hulse W, Bahr TM, Fredrickson L, et al. · Transfusion · 2020
Other devices of this type
Also filed under product code MMY.
- Liposorber(R) LA-15 System Adsorption ColumnKaneka Pharma America Corp. · PMA 2025
- H.e.l.p. Plasmat Futura SystemB. Braun Avitum AG · PMA 2015
- Heparin-Induced Extracorporeal Lipoprotein Precipitation (H.e.l.p.) Futura Apheresis SystemB. Braun Avitum AG · PMA 2012
- B.braun,s Heparin-Induced Extracorporeal Lipoprotein Precipitation (H.e.l.p) SystemB. Braun Avitum AG · PMA 2002
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.